Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Laube

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 9, 2017
"Hydrous <sup>18</sup>F-fluoroethylation" - Leaving off the azeotropic dryingTorsten Kniess, Markus Laube, Jörg Steinbach
Amino Acids|October 14, 2016
Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinityChristoph Tondera, Markus Laube, Jens Pietzsch
Molecules (Basel, Switzerland)|June 14, 2013
Radiolabeled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity--a critical updateMarkus Laube, Torsten Kniess, Jens Pietzsch
Antioxidants (Basel, Switzerland)|April 23, 2016
Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven ReviewMarkus Laube, Torsten Kniess, Jens Pietzsch
Molecules (Basel, Switzerland)|October 27, 2019
Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-<i>hi</i>]indoles and Their Potential ProdrugsMarkus Laube, Cemena Gassner, Torsten Kniess, et al.
Dalton Transactions (Cambridge, England : 2003)|August 23, 2017
Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infectionTorsten Kniess, Markus Laube, Frank Wüst, et al.
ACS Omega|June 15, 2026
Nitrosoarenes as Versatile Precursors for <sup>18</sup>F‑FluorinationMarkus Laube, Silvia Roscales, Jens Pietzsch, et al.
Clinical Hemorheology and Microcirculation|October 24, 2014
Organotypical vascular model for characterization of radioprotective compounds: studies on antioxidant 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitorsSandra Ullm, Markus Laube, Nicole Bechmann, et al.
Clinical Hemorheology and Microcirculation|December 31, 2014
Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitroJens Pietzsch, Markus Laube, Nicole Bechmann, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2019
Fluorine-18 Labeling of S100 Proteins for Small Animal Positron Emission TomographyMarkus Laube, Torsten Kniess, Christin Neuber, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 9, 2017
"Hydrous <sup>18</sup>F-fluoroethylation" - Leaving off the azeotropic dryingTorsten Kniess, Markus Laube, Jörg Steinbach
Amino Acids|October 14, 2016
Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinityChristoph Tondera, Markus Laube, Jens Pietzsch
Molecules (Basel, Switzerland)|June 14, 2013
Radiolabeled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity--a critical updateMarkus Laube, Torsten Kniess, Jens Pietzsch
Antioxidants (Basel, Switzerland)|April 23, 2016
Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven ReviewMarkus Laube, Torsten Kniess, Jens Pietzsch
Molecules (Basel, Switzerland)|October 27, 2019
Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-<i>hi</i>]indoles and Their Potential ProdrugsMarkus Laube, Cemena Gassner, Torsten Kniess, et al.
Dalton Transactions (Cambridge, England : 2003)|August 23, 2017
Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infectionTorsten Kniess, Markus Laube, Frank Wüst, et al.
ACS Omega|June 15, 2026
Nitrosoarenes as Versatile Precursors for <sup>18</sup>F‑FluorinationMarkus Laube, Silvia Roscales, Jens Pietzsch, et al.
Clinical Hemorheology and Microcirculation|October 24, 2014
Organotypical vascular model for characterization of radioprotective compounds: studies on antioxidant 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitorsSandra Ullm, Markus Laube, Nicole Bechmann, et al.
Clinical Hemorheology and Microcirculation|December 31, 2014
Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitroJens Pietzsch, Markus Laube, Nicole Bechmann, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2019
Fluorine-18 Labeling of S100 Proteins for Small Animal Positron Emission TomographyMarkus Laube, Torsten Kniess, Christin Neuber, et al.
Pageof 6